Population
Patients with acute myocardial infarction (STEMI and NSTEMI)
Design
Review
Follow-up
6 months
Authors
Loading...
NSTEMI mortality plateau since 2010 warrants renewed prevention efforts; leaves open whether targeted trials can resume prior declines.
While 6-month mortality for STEMI continued to decline until 2015, mortality improvements for NSTEMI patients appear to have plateaued since 2010.
Puymirat et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: